https://www.selleckchem.com/products/cpi-1205.html
Female gender, age69 years, PR interval160 ms and cortical-subcortical infarct type at enrolment were independently associated with an increased risk of SCAF. In a real-world population, ICM detected SCAF in more than a quarter of CS patients. This experience confirms the relevance of implanting CS patients, for maximizing the possibilities to detect AF, following failure of Holter monitoring, according to guidelines. However, there is need to demonstrate that shift to oral anticoagulation following SCAF detection is associated
Gefällt mir
Kommentar
Teilen
